The estimation of radiation effect to cancer patients treated with beam-therapy by means of analysis of chromosomal aberrations in blood lymphocytes

«Radiation and Risk», 2019, vol. 28, No. 2, pp.87-101

DOI: 10.21870/0131-3878-2019-28-2-87-101

Authors

Khvostunov I.K.1 – Head of Lab., D. Sc., Biol. Contacts: 4 Korolev str., Obninsk, Kaluga region, Russia, 249036. Tel.: (484) 399-73-92; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Kursova L.V.1 – Lead. Researcher, C. Sc., Med.
Sevan’kaev A.V.1 – Head of Lab., D. Sc., Biol.
Ragulin Yu.A.1 – Head of Dep., C. Sc., Med.
Shepel N.N.1 – Senior Researcher, C. Sc., Biol.
Korovchuk O.N.1 – Researcher.
Khvostunova T.I.1 – Researcher.
Pyatenko V.S.1,2 – Lead. Researcher, C. Sc., Biol.

1A. Tsyb MRRC, Obninsk, Russia
2N.M. Emanuel Institute of Biochemical Physics RAS, Moscow, Russia

Abstract

The goal of the study was to investigate local and whole-bogy doses to lung cancer patients received fractionated beam-therapy. The biological dosimetry based on the analysis of chromosomal aberrations in blood lymphocytes was used. The group comprised 25 lung cancer patients that exhibited II to IV developmental clinical stage has been examined. All the patients received the accumulated tumor dose ranged 47.5 to 70 Gy by means of &gamma-ray 60Co radiation machines «Luch» or «Rokus». The blood was sampled as following: before treatment, after the first day, after the complete course of beam-therapy and time-by-time during the post treatment period up to about two years. The chromosomal aberrations were analyzed in the first mitosis cells using conventional method. It was found that individual response of patients to beam-therapy varied greatly even after comparable irradiation conditions. The examined groups have been statistically subdivided into three subgroup of high, intermediate and low radiation sensitivity using observed frequency of chromosomal radiation markers. The tumor dose and side whole-body dose were estimated for all the subgroups by means of biodosimetry model based on incomplete-repair theory. The specialty of cytogenetic dose assessment of lung cancer patients found in this study confirms the necessity for individual practice toward planning and executing the therapeutic regimen of cancer patients. The increasing of efficiency and avoiding of side effect could be expected in this way.

Key words
Radiation effect, chromosomal aberrations, blood lymphocytes, beam-therapy, wholebody dose, lung cancer, radiotherapy, dicentric, centric ring, acentric.

References

1. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow, Р. Hertsen MORI, 2017. 250 p. (In Russian).

2. Stolbovoy A.V., Zalyalov I.F. Radiobiology models and clinical radiation oncology. Onkologiya. Zhurnal im. P.A. Gertsena – Herzen P.A. Oncology Journal, 2016, vol. 5, no. 6, pp. 88-96. (In Russian).

3. Cytogenetic analysis for radiation dose assessment. A Manual. Technical Reports Series IAEA, No 405. Vienna, IAEA, 2001. 127 p.

4. Simon S.L., Bailiff I., Bouvill A., Fattibene P., Kleinerman R.A., Lloyd D.C., McKeever S.W.S., Romanyukha A., Sevan’kaev A.V, Tucker J.D., Wieser A. BiodosEPR-2006 consensus committee report on biodosimetric methods to evaluate radiation doses at long times after exposure. Radiat. Meas., 2007, vol. 42, no. 6-7, pp. 948-971.

5. Roch-le vre S., Pouzoulet F., Giraudet A.L., Voisin P.A., Vaurijoux A., Gruel G., Gr goire E., Buard V., Delbos M., Voisin Ph., Bourhis J., Roy L. Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy. Br. J. Radiol., 2010, vol. 83, no. 993, pp. 759-766.

6. Matsuoka A., Yamada K., Hayashi M., Sofuni T. Chromosomal aberrations detected by chromosome painting in lymphocytes from cancer patients given high doses of therapeutic X-rays. J. Radiat. Res., 1996, vol. 37, no. 4, pp. 257-265.

7. Vorobtsova I., Darroudi F., Semyonov A., Kanayeva A., Timofeyeva N., Yakovleva T., Zharinov G., Natarajan A.T. Analysis of chromosome aberrations by FISH and Giemsa assays in lymphocytes of cancer patients undergoing whole-body irradiation: Comparison of in vivo and in vitro irradiation. Int. J. Radiat. Biol., 2001, vol. 77, no. 11, pp. 1123-1131.

8. Senthamizhchelvan S., Pant G.S., Rath G.K., Julka P.K., Nair O., Joshi R.C., Malhotra A., Pandey R.M. Biodosimetry using chromosome aberrations in human lymphocytes. Radiat. Prot. Dosim., 2007, vol. 123, no. 2, pp. 241-245.

9. Durante M., Yamada S., Ando K., Furusawa Y., Kawata T., Majima H., Nakano T., Tsujii H. Measurements of the equivalent whole-body dose during radiation therapy by cytogenetic methods. Phys. Med. Biol., 1999, vol. 44, no. 5, pp. 1289-1298.

10. Lee R., Yamada S., Yamamoto N., Miyamoto T., Ando K., Durante M., Tsujii H. Chromosomal aberrations in lymphocytes of lung cancer patients treated with carbon ions. J. Radiat. Res., 2004, vol. 45, no. 2, pp. 195-199.

11. Sak A., Grehl S., Erichsen P., Engelhard M., Grannass A., Levegrün S., Pöttgen C., Groneberg M., Stuschke M. Gamma H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: dependence on the dose distribution, irradiated site and time from start of treatment. Int. J. Radiat. Biol., 2007, vol. 83, no. 10, pp. 639-652.

12. Matsubara S., Sasaki M.S., Adachi T. Dose response relationship of lymphocyte chromosome aberrations in locally irradiated persons. J. Radiat. Res., 1974, vol. 15, no. 4, pp. 189-196.

13. Sasaki M.S., Miyata H. Biological dosimetry in atomic bomb survivors. Nature, 1968, vol. 220, no. 5173, pp. 1189-1193.

14. Dolphin G.W. Biological dosimetry with particular reference to chromosomal aberration analyses. A review of methods (IAEA-SM-119/4). Handling of radiation accidents. Proceedings of a Symposium on the Handling of Radiation Accidents. Vienna, IAEA, 1969, pp. 215-224.

15. Barquinero J.F., Barrios L., Caballin M.R., Miró R., Ribas M., Egozcue J. Biological dosimetry in simulated in vitro partial irradiations. Int. J. Radiat. Biol., 1997, vol. 71, no. 4, pp. 435-440.

16. Khvostunov I.K., Kursova L.V., Shepel N.N., Ragulin Yu.A., Sevan’kaev A.V., Gulidov I.A., Glazyrin D.A., Ivanova I.N. The estimation of appropriateness of chromosomal aberration assay as a biological dosimetry based on cytogenetic investigation of lung cancer patients given non-uniform fractional exposures to high doses of therapeutic 60Co γ-rays. Radiatsionnaya biologiya. Radioekologiya. – Radiation Biology. Radioecoligy, 2012, vol. 52, no. 5, pp. 467-480. (In Russian).

17. Khvostunov I.K., Shepel N.N., Sevan’kaev A.V., Nugis V.Yu., Korovchuk O.N., Kursova L.V., Ragulin Yu.A. The improvement of methods of biological dosimetry by analysis of chromosomal aberrations induced in human blood lymphocytes in vitro and in vivo. Mediko-biologicheskiye problemy zhiznedeyatelnosti – Medical and Biological Problems of Life Activity, 2013, vol. 9, no. 1, pp. 135-147. (In Russian).

18. Brenner D.J., Hlatky L.R., Hahnfeldt P.J., Huang Y., Sachs R.K. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat. Res., 1998, vol. 150, no. 1, pp. 83-91.

19. Nilsson P., Thames H.D., Joiner M.C. A generalized formulation of the “Incomplete-repair” model for cell survival and tissue response to fractionated low dose-rate irradiation. Int. J. Radiat. Biol., 1990, vol. 57, no. 1, pp. 127-142.

20. Edwards A.A., Lloyd D.C., Purrott R.J. Radiation induced chromosome aberration and the Poisson distribution. Radiat. Environ. Biophys., 1979, vol. 16, no. 2, pp. 89-100.

21. Thames H.D. An “incomplete-repair” model for survival after fractionated and continuous irradiation. Int. J. Radiat. Biol., 1985, vol. 47, no. 3, pp. 319-339.

22. Bhat N.N., Rao B.S. Dose rate effect on micronuclei induction in cytokinesis blocked human peripheral blood lymphocytes. Radiat. Prot. Dosim., 2003, vol. 106, no. 1, pp. 45-52.

23. Kaprin A.D., Galkin V.N., Zhavoronkov L.P., Ivanov V.K., Ivanov S.A., Romanko Yu.S. Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice. Radiatsiya i risk – Radiation and Risk, 2017, vol. 26, no. 2, pp. 26-40. (In Russian).

Full-text article (in Russian)